Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F2SA
|
|||
| Former ID |
DNC002388
|
|||
| Drug Name |
BPKDi
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H28N6O
|
|||
| Canonical SMILES |
C1CCC(CC1)NC2=NC=CC(=C2)C3=NC(=CC(=C3)C(=O)N)N4CCNCC4
|
|||
| InChI |
1S/C21H28N6O/c22-21(28)16-12-18(26-20(14-16)27-10-8-23-9-11-27)15-6-7-24-19(13-15)25-17-4-2-1-3-5-17/h6-7,12-14,17,23H,1-5,8-11H2,(H2,22,28)(H,24,25)
|
|||
| InChIKey |
XNWDRALEEPGBHB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein kinase D (PRKD1) | Target Info | Inhibitor | [1] |
| NetPath Pathway | FSH Signaling Pathway | |||
| TGF_beta_Receptor Signaling Pathway | ||||
| Panther Pathway | Angiogenesis | |||
| EGF receptor signaling pathway | ||||
| VEGF signaling pathway | ||||
| CCKR signaling map ST | ||||
| Pathway Interaction Database | LPA receptor mediated events | |||
| IGF1 pathway | ||||
| Reactome | Sphingolipid de novo biosynthesis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Protein kinase D as a potential new target for cancer therapy. Biochim Biophys Acta. 2010 Dec;1806(2):183-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.